Healthy volunteers help test drug combo for safer breast cancer dosing
NCT ID NCT07229560
First seen Nov 17, 2025 · Last updated May 09, 2026 · Updated 22 times
Summary
This study looked at how itraconazole, an antifungal drug, changes the way the body processes HRS-8080, a medicine being developed for breast cancer. Sixteen healthy adults took HRS-8080 alone and then with itraconazole to measure drug levels and safety. The goal was to understand potential drug interactions before testing in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
Conditions
Explore the condition pages connected to this study.